Angellotti Edith, Pittas Anastassios G
Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, Massachusetts 02111.
Department of Medical, Surgical, Neurologic, Metabolic and Aging Sciences, University of Campania Luigi Vanvitelli, Naples 80128, Italy.
Endocrinology. 2017 Jul 1;158(7):2013-2021. doi: 10.1210/en.2017-00265.
Evidence on biological plausibility from mechanistic studies and highly consistent data from observational studies raise the possibility that optimizing vitamin D status may reduce the risk of type 2 diabetes. However, the observational nature of cohort studies precludes a definitive assessment of cause and effect because residual confounding or reverse causation cannot be excluded. Confounding is especially problematic with studies of vitamin D because blood 25-hydoxyvitamin D concentration is not only an excellent biomarker of vitamin D status, reflecting intake or biosynthesis, but also an excellent marker of good overall health. Results from underpowered trials and post hoc analyses of trials designed for nondiabetic outcomes do not support a role of vitamin D supplementation for prevention of type 2 diabetes among people with normal glucose tolerance. Whether vitamin D supplementation may have a role in the prevention of diabetes in high-risk populations remains to be seen. Adequately powered, randomized trials in well-defined populations (e.g., prediabetes) are ongoing and expected to establish whether vitamin D supplementation lowers risk of diabetes.
来自机制研究的生物学合理性证据以及观察性研究的高度一致数据表明,优化维生素D状态可能会降低2型糖尿病的风险。然而,队列研究的观察性质排除了对因果关系的明确评估,因为无法排除残余混杂因素或反向因果关系。维生素D研究中的混杂问题尤为突出,因为血液中25-羟基维生素D浓度不仅是维生素D状态的极佳生物标志物,反映了摄入量或生物合成,也是整体健康状况良好的极佳标志物。效力不足的试验结果以及针对非糖尿病结局设计的试验的事后分析并不支持补充维生素D在糖耐量正常人群中预防2型糖尿病的作用。补充维生素D在高危人群预防糖尿病中是否起作用仍有待观察。在明确界定的人群(如糖尿病前期)中进行的足够有力的随机试验正在进行中,有望确定补充维生素D是否能降低糖尿病风险。